Latest Breaking News On - Joyce allaire - Page 3 : comparemela.com

Vera Therapeutics Presents 72-week eGFR Stabilization and

Vera Therapeutics Presents 72-week eGFR Stabilization and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Joyce allaireMari purpuraRichard lafayetteMarshall fordyceVera therapeutics incDivision of nephrologyCongress paper selection committeeUniversity of aachenEuropean renal association congressExchange commissionResults are consistent withPaper selectionFree communicationOpen label extensionIga nephropathyPersistent proteinuria

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Joyce allaireMarshall fordyceRichard lafayetteMari purpuraCongress paper selection committeeGlobenewswire incDivision of nephrologyUniversity of aachenExchange commissionEuropean renal association congressStanford glomerular disease centerStanford university medical centerVera therapeutics incRenal association congressResults are consistent withPaper selection

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesShiraj senJoyce allaireSensei bioMichael biegaSensei biotherapeuticsRon weitzmanClinical researchGlobenewswire incExchange commissionSensei biotherapeutics incAmerican society of clinical oncologyMedical oncologistChief medical officerClinical oncologyAnnual meeting

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Joyce allaireProspectus departmentExchange commissionErasca incJp morgan securitiesBroadridge financial solutionsLifesci advisorsAnnounces closingUnderwritten offeringCommon stockFull exerciseUnderwriter optionPurchase additionalBofa securitiesIsland avenueTryon street

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares - Erasca (NASDAQ:ERAS)

SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with

Joyce allaireProspectus departmentBroadridge financial solutionsJp morgan securitiesExchange commissionLifesci advisorsErasca incBofa securitiesIsland avenueTryon streetPrivate securities litigation reform actSci advisors